{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:04Z","timestamp":1791216484517,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2000,8,1]],"date-time":"2000-08-01T00:00:00Z","timestamp":965088000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2000,8]]},"DOI":"10.1023\/a:1007049015148","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T08:59:48Z","timestamp":1040547588000},"page":"357-370","source":"Crossref","is-referenced-by-count":108,"title":["Nepafenac, a Unique Nonsteroidal Prodrug with Potential Utility in the Treatment of Trauma-Induced Ocular Inflammation: I. Assessment of Anti-Inflammatory Efficacy"],"prefix":"10.1007","volume":"24","author":[{"given":"Daniel A.","family":"Gamache","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustav","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton T.","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joan M.","family":"Spellman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M.","family":"Yanni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"222655_CR1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/BF01964911","volume":"7","author":"L. F. Sancilio","year":"1977","unstructured":"SANCILIO, L. F., D. L. REESE, C. CHEUNG, and R. S. ALPHIN. 1977. AHR-5850: a potent anti-inflammatory compound. Agents Actions, 7:133-144.","journal-title":"Agents Actions"},{"key":"222655_CR2","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/jm00377a001","volume":"27","author":"D. A. Walsh","year":"1984","unstructured":"WALSH, D. A., H. W. MORAN, D. A. SHAMBLEE, I. M. UWAYDAH, W. J. WELSTEAD, JR., L. F. SANCILIO, and W. N. DANNENBURG. 1984. Anti-inflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino-3-benzoylphenylacetic acid and analogues. J. Med. Chem., 27:1379-1388.","journal-title":"J. Med. Chem."},{"key":"222655_CR3","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1021\/jm00170a039","volume":"33","author":"D. A. Walsh","year":"1990","unstructured":"WALSH, D. A., H. W. MORAN, D. A. SHAMBLEE, W. J. WELSTEAD, JR., J. C. NOLAN, L. F. SANCILIO, and G. GRAFF. 1990. Anti-inflammatory agents. 4. Syntheses and biological evaluation of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid and 2-amino-3-(4-chlorobenzoyl) benzeneacetic acid. J. Med. Chem., 33:2296-2304.","journal-title":"J. Med. Chem."},{"key":"222655_CR4","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/j.1875-9114.1986.tb03482.x","volume":"6","author":"A. K. Jain","year":"1986","unstructured":"JAIN, A. K., C. C. HUNLEY, J. KUEBEL, F. G. MCMAHON, and J. J. RYAN. 1986. Analgesic efficacy of amfenac, aspirin and placebo after extraction of impacted teeth. Pharmacotherapy, 6:236-240.","journal-title":"Pharmacotherapy"},{"key":"222655_CR5","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1248\/bpb1978.11.612","volume":"11","author":"T. Hiranuma","year":"1988","unstructured":"HIRANUMA, T., S. KATO, and M. HACHISU. 1988. Analgesic action of amfenac Na, a nonsteroidal anti-inflammatory agent. J. Pharmacobiodyn., 11:612-619.","journal-title":"J. Pharmacobiodyn."},{"key":"222655_CR6","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1097\/00055735-199808000-00007","volume":"9","author":"J. Nichols","year":"1998","unstructured":"NICHOLS, J., and R. W. SNYDER. 1998. Topical nonsteroidal anti-inflammatory agents in ophthalmology. Curr. Opin. Ophthalmol., 9:40-44.","journal-title":"Curr. Opin. Ophthalmol."},{"key":"222655_CR7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/0003-2697(79)90591-8","volume":"96","author":"H. W. Cook","year":"1979","unstructured":"COOK, H. W., G. FORD, and W. E. M. LANDS. 1979. Instrumental improvements for rapid, detailed kinetic studies of oxygenase activity. Anal. Biochem., 96:341-351.","journal-title":"Anal. Biochem."},{"key":"222655_CR8","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/0090-6980(89)90130-5","volume":"38","author":"G. Graff","year":"1989","unstructured":"GRAFF., G., and L. A. ANDERSON. 1989. 1-[4-[3-[4-[Bis(4-fluorophenyl)hydroxymethyl]-1-piperidinyl]propoxy]-3-methoxyphenyl]ethanone (AHR-5333): A selective human blood neutrophil 5-lipoxygenase inhibitor. Prostaglandins, 38:473-496.","journal-title":"Prostaglandins"},{"key":"222655_CR9","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1076\/ocii.6.4.227.4030","volume":"6","author":"G. Graff","year":"1998","unstructured":"GRAFF, G., M. T. BRADY, D. A. GAMACHE, J. M. SPELLMAN, and J. M. YANNI. 1998. Transient loss of prostaglandin synthetic capacity in the rabbit iris-ciliary body following anterior chamber paracentesis. Ocular Immunol. Inflamm., 6:227-238.","journal-title":"Ocular Immunol. Inflamm."},{"key":"222655_CR10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0003-2697(85)90628-1","volume":"148","author":"W. S. Powell","year":"1985","unstructured":"POWELL, W. S. 1985. Reversed-phase high-pressure liquid chromatography of arachidonic acid metabolites formed by cyclooxygenase and lipoxygenase. Anal. Biochem., 148:59-69.","journal-title":"Anal. Biochem."},{"key":"222655_CR11","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"M. M. Bradford","year":"1976","unstructured":"BRADFORD, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72:248-254.","journal-title":"Anal. Biochem."},{"key":"222655_CR12","doi-asserted-by":"crossref","first-page":"4863","DOI":"10.1073\/pnas.72.12.4863","volume":"72","author":"L. H. Rome","year":"1975","unstructured":"ROME, L. H., and W. E. M. LANDS. 1975. Structural requirements for time-dependent inhibition of prostaglandin biosynthesis by anti-inflammatory drugs. Proc. Natl. Acad. Sci. U.S.A., 72:4863-4865.","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"222655_CR13","unstructured":"KE, T.-L., G. GRAFF, J. M. SPELLMAN, and J. M. YANNI. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced acute ocular inflammation. II. In vitro bioactivation and permeation of external ocular barriers. (In press.)"},{"key":"222655_CR14","first-page":"39","volume-title":"The Ocular Effects of Prostaglandins and Other Eicosanoids","author":"P. S. Kulkarni","year":"1989","unstructured":"KULKARNI, P. S., and B. D. SRINIVASAN. Cyclooxygenase and lipoxygenase pathways in anterior uvea and conjunctiva. 1989. In: The Ocular Effects of Prostaglandins and Other Eicosanoids, Editors; Bito L. Z., J. Sternschantz. Alan R. Liss, Inc., New York, 39-52."},{"issue":"suppl","key":"222655_CR15","first-page":"851","volume":"39","author":"K. N. Sall","year":"1998","unstructured":"SALL, K. N., and T. A. PASQUINE. The Nepafenac Dose-Response Study Group. 1998. Nepafenac is effective in reducing anterior chamber inflammation following cataract surgery. Invest. Ophthalmol. Vis. Sci., 39(suppl):851.","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"222655_CR16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/archopht.1994.01090190039018","volume":"112","author":"L. M. Jampol","year":"1994","unstructured":"JAMPOL, L. M., S. JAIN, B. PUDZISZ, and R. N. WEINREB. 1994. Nonsteroidal anti-inflammatory drugs and cataract surgery. Arch. Ophthalmol., 112:891-894.","journal-title":"Arch. Ophthalmol."},{"key":"222655_CR17","first-page":"138","volume":"1","author":"M. B. Abelson","year":"1994","unstructured":"ABELSON, M. B., and L. PARVER. 1994. How to handle CME in pseudophakes. Rev. Ophthalmol., 1:138-139.","journal-title":"Rev. Ophthalmol."},{"key":"222655_CR18","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0886-3350(13)80485-3","volume":"21","author":"A. P. Ginsburg","year":"1995","unstructured":"GINSBURG, A. P., J. K. CHEETHAM, R. E. DEGRYSE, and M. ABELSON. 1995. Effects of flurbiprofen and indomethacin on acute cystoid macular edema after cataract surgery: Functional vision and contrast sensitivity. J. Cataract Refract. Surg., 21:82-92.","journal-title":"J. Cataract Refract. Surg."},{"key":"222655_CR19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/BF00175922","volume":"230","author":"M. Peterson","year":"1992","unstructured":"PETERSON, M., M. O. YOSHIZUMI, R. HELPLER, B. MONDINO, and A. KREIGER. 1992. Topical indomethacin in the treatment of chronic cystoid macular edema. Graefe's Arch. Clin. Exp. Ophthalmol., 230:401-405.","journal-title":"Graefe's Arch. Clin. Exp. Ophthalmol."},{"key":"222655_CR20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1076\/ceyr.18.2.79.5386","volume":"18","author":"E. I. M. Johnson","year":"1999","unstructured":"JOHNSON, E. I. M., M. E. DUNLOP, and R. G. LARKINS. 1999. Increased vasodilatory prostaglandin production in the diabetic rat retinal vasculature. Curr. Eye Res., 18:79-82.","journal-title":"Curr. Eye Res."}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007049015148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1007049015148\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1007049015148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T12:52:26Z","timestamp":1748263946000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1007049015148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,8]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2000,8]]}},"alternative-id":["222655"],"URL":"https:\/\/doi.org\/10.1023\/a:1007049015148","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,8]]}}}